Physicians worldwide are welcome to refer patients to City of Hope. When you refer your patient, you can do so with the utmost confidence that our staff will provide the best care possible.
City of Hope has an enduring commitment to continuing medical education, sharing advances in cancer research and treatment with the healthcare community through conferences and symposia.
We provide an innovative series of educational programs for nurses, radiation therapists, pharmacists, cancer researchers and others.
City of Hope offers a range of valuable programs and training for postdoctoral trainees, medical professionals and our own staff.
The aggressive pursuit to discover better ways to help patients now - not years from now - places City of Hope among the worldwide leaders in administering clinical trials.
There are many misconceptions about using vitamins and supplements as a fast and easy way to get the nutrients your body requires, especially since everything from antioxidant rich teas to anti-inflammatory omega fatty acids are now widely available in pill form. But when it comes to cancer prevention, there are no quick fixes. Here is what you need to know before relying on vitamins and supplements for their cancer-fighting properties.
People have a lot of ideas these days about what might help prevent cancer: alkaline water, going vegan, a ketogenic diet – even fasting. But none of these dieting trends are likely to have much of an effect on cancer risk, according to City of Hope dieticians.
Despite a wave of new targeted therapies being approved to treat kidney cancer, many of those therapies have been challenging to use because of the difficulty in obtaining cancer tissue for genomic testing. Now, researchers may have found a way to combat this problem: the liquid biopsy.
City of Hope scientists have identified a new, potential treatment for breast cancers that exhibit a resistance against a common type of drug used to treat the disease.
City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR-T cells dramatically improved quality of life for patient with recurrent glioblastoma.